Sfoglia per Autore
Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth
1998-01-01 BARDELLI A.; LONGATI P.; GRAMAGLIA D.; BASILICO C.; TAMAGNONE L.; GIORDANO S; BALLINARI D.; MICHIELI P.; P. COMOGLIO
A peptide representing the carboxyl-terminal tail of the met receptor inhibits kinase activity and invasive growth.
1999-01-01 A. BARDELLI; P. LONGATI; TA. WILLIAMS; S. BENVENUTI; P.M. COMOGLIO
Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family.
1999-01-01 OLIVERO M ;VALENTE G ;BARDELLI A ;LONGATI P ;FERRERO N ;CRACCO C ;TERRONE C ;ROCCA-ROSSETTI S ;COMOGLIO PM ;DI RENZO MF
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists.
1999-01-01 P. MICHIELI; C. BASILICO; S. PENNACCHIETTI; A. MAFFE'; L. TAMAGNONE; S. GIORDANO; A. BARDELLI; P.M. COMOGLIO
Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis.
1999-01-01 A. BARDELLI; M.L. BASILE; E. AUDERO; S. GIORDANO; S. WENNSTROM; S. MENARD; P.M. COMOGLIO; C. PONZETTO
Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET.
1999-01-01 E. VIGNA; D. GRAMAGLIA; P. LONGATI; A. BARDELLI; P.M. COMOGLIO
MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential.
1999-01-01 WILLIAMS TA; LONGATI P; PUGLIESE L; GUAL P; A. BARDELLI; MICHIELI P
Different point mutations in the met oncogene elicit distinct biological properties.
2000-01-01 GIORDANO S; MAFFÈ A; WILLIAMS T A; ARTIGIANI S; GUAL P; BARDELLI A; BASILICO C; MICHIELI P; P. COMOGLIO
Carcinogen-specific induction of genetic instability.
2001-01-01 A. BARDELLI; CAHILL D; LEDERER G; SPEICHER M; KINZLER K; VOGELSTEIN B; LENGAUER C
Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene.
2001-01-01 LONGATI P ;COMOGLIO PM ;BARDELLI A
A phosphatase associated with metastasis of colorectal cancer.
2001-01-01 SAHA S; A. BARDELLI; BUCKHAULTS P; VELCULESCU VE; RAGO C; ST CROIX B; ROMANS KE; CHOTI MA; LENGAUER C; KINZLER KW; VOGELSTEIN B
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.
2002-01-01 RAJAGOPALAN H ;BARDELLI A ;LENGAUER C ;KINZLER KW ;VOGELSTEIN B ;VELCULESCU VE
A Phosphatase Associated with Metastasis
2003-01-01 Saurabh Saha; Kenneth Kinzler; Bert Vogelstein; Alberto Bardelli
Mutational analysis of the tyrosine kinome in colorectal cancers.
2003-01-01 A. BARDELLI; PARSONS DW; SILLIMAN N; PTAK J; SZABO S; SAHA S; MARKOWITZ S; WILLSON JK; PARMIGIANI G; KINZLER KW; VOGELSTEIN B; VELCULESCU VE
Identifying tumor origin using a gene expression-based classification map.
2003-01-01 BUCKHAULTS P; ZHANG Z; CHEN YC; WANG TL; ST CROIX B; SAHA S; A. BARDELLI; MORIN PJ; POLYAK K; HRUBAN RH; VELCULESCU VE; SHIH IEM
PRL-3 expression in metastatic cancers
2003-01-01 BARDELLI A; SAHA S; SAGER JA; ROMANS KE; XIN B; MARKOWITZ SD; LENGAUER C; VELCULESCU VE; KINZLER KW; VOGELSTEIN B
Tyrosine Kinome
2004-01-01 BARDELLI A; PARSONS W; VELCULESCU V; KINZLER KW; VOGELSTEIN B
p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells
2004-01-01 BACHMAN KE; BLAIR BG; BRENNER K; BARDELLI A; ARENA S; ZHOU S; HICKS J; DE MARZO AM; ARGANI P; PARK BH
SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells
2004-01-01 KOHLI M; YU J; SEAMAN C; BARDELLI A; KINZLER KW; VOGELSTEIN B; LENGAUER C; ZHANG L
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients
2004-01-01 WANG TL; DIAZ LA JR; ROMANS K; A. BARDELLI; SAHA S; GALIZIA G; CHOTI M; DONEHOWER R; PARMIGIANI G; SHIH IEM; IACOBUZIO-DONAHUE C; KINZLER KW; VOGELSTEIN; B; LENGAUER C; VELCULESCU VE
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth | 1998 | BARDELLI A.; LONGATI P.; GRAMAGLIA D.; BASILICO C.; TAMAGNONE L.; GIORDANO S; BALLINARI D.; MICHIELI P.; P. COMOGLIO | |
A peptide representing the carboxyl-terminal tail of the met receptor inhibits kinase activity and invasive growth. | 1999 | A. BARDELLI; P. LONGATI; TA. WILLIAMS; S. BENVENUTI; P.M. COMOGLIO | |
Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family. | 1999 | OLIVERO M ;VALENTE G ;BARDELLI A ;LONGATI P ;FERRERO N ;CRACCO C ;TERRONE C ;ROCCA-ROSSETTI S ;COMOGLIO PM ;DI RENZO MF | |
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists. | 1999 | P. MICHIELI; C. BASILICO; S. PENNACCHIETTI; A. MAFFE'; L. TAMAGNONE; S. GIORDANO; A. BARDELLI; P.M. COMOGLIO | |
Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis. | 1999 | A. BARDELLI; M.L. BASILE; E. AUDERO; S. GIORDANO; S. WENNSTROM; S. MENARD; P.M. COMOGLIO; C. PONZETTO | |
Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET. | 1999 | E. VIGNA; D. GRAMAGLIA; P. LONGATI; A. BARDELLI; P.M. COMOGLIO | |
MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential. | 1999 | WILLIAMS TA; LONGATI P; PUGLIESE L; GUAL P; A. BARDELLI; MICHIELI P | |
Different point mutations in the met oncogene elicit distinct biological properties. | 2000 | GIORDANO S; MAFFÈ A; WILLIAMS T A; ARTIGIANI S; GUAL P; BARDELLI A; BASILICO C; MICHIELI P; P. COMOGLIO | |
Carcinogen-specific induction of genetic instability. | 2001 | A. BARDELLI; CAHILL D; LEDERER G; SPEICHER M; KINZLER K; VOGELSTEIN B; LENGAUER C | |
Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene. | 2001 | LONGATI P ;COMOGLIO PM ;BARDELLI A | |
A phosphatase associated with metastasis of colorectal cancer. | 2001 | SAHA S; A. BARDELLI; BUCKHAULTS P; VELCULESCU VE; RAGO C; ST CROIX B; ROMANS KE; CHOTI MA; LENGAUER C; KINZLER KW; VOGELSTEIN B | |
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. | 2002 | RAJAGOPALAN H ;BARDELLI A ;LENGAUER C ;KINZLER KW ;VOGELSTEIN B ;VELCULESCU VE | |
A Phosphatase Associated with Metastasis | 2003 | Saurabh Saha; Kenneth Kinzler; Bert Vogelstein; Alberto Bardelli | |
Mutational analysis of the tyrosine kinome in colorectal cancers. | 2003 | A. BARDELLI; PARSONS DW; SILLIMAN N; PTAK J; SZABO S; SAHA S; MARKOWITZ S; WILLSON JK; PARMIGIANI G; KINZLER KW; VOGELSTEIN B; VELCULESCU VE | |
Identifying tumor origin using a gene expression-based classification map. | 2003 | BUCKHAULTS P; ZHANG Z; CHEN YC; WANG TL; ST CROIX B; SAHA S; A. BARDELLI; MORIN PJ; POLYAK K; HRUBAN RH; VELCULESCU VE; SHIH IEM | |
PRL-3 expression in metastatic cancers | 2003 | BARDELLI A; SAHA S; SAGER JA; ROMANS KE; XIN B; MARKOWITZ SD; LENGAUER C; VELCULESCU VE; KINZLER KW; VOGELSTEIN B | |
Tyrosine Kinome | 2004 | BARDELLI A; PARSONS W; VELCULESCU V; KINZLER KW; VOGELSTEIN B | |
p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells | 2004 | BACHMAN KE; BLAIR BG; BRENNER K; BARDELLI A; ARENA S; ZHOU S; HICKS J; DE MARZO AM; ARGANI P; PARK BH | |
SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells | 2004 | KOHLI M; YU J; SEAMAN C; BARDELLI A; KINZLER KW; VOGELSTEIN B; LENGAUER C; ZHANG L | |
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients | 2004 | WANG TL; DIAZ LA JR; ROMANS K; A. BARDELLI; SAHA S; GALIZIA G; CHOTI M; DONEHOWER R; PARMIGIANI G; SHIH IEM; IACOBUZIO-DONAHUE C; KINZLER KW; VOGELSTEIN; B; LENGAUER C; VELCULESCU VE |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile